secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAGENICS INC (OGEN)
CIK:        0001174940
Form:       8-K
Filed at:   2025-07-02T23:59:59+00:00
Accession:  0001641172-25-017575
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oragenics closes $16.5M public offering of Series H Preferred Stock and Warrants
--------------------------------------------------------------------------------

- Issued 660,000 shares of Series H Convertible Preferred Stock at $25/unit with warrants to buy 660,000 additional shares.
- Preferred Stock converts to common at $2.50 per share; warrants exercise at $25/share for 5 years.
- Gross proceeds ~$16.5M; net ~$15M after fees; potential additional $16.5M if all warrants exercised.
- Net proceeds to fund ONP-002 concussion trials, repay $3M bridge note, and general corporate purposes.
- Preferred Stock carries 9% cumulative dividend payable in common stock; no voting rights except as law requires.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1174940/000164117225017575/0001641172-25-017575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1174940/000164117225017575/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-017575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer